The Food and Drug Administration (FDA) performed an inspection of Lenox Hill Hospital in New York on April 29, evaluating protocols for blood and blood products, according to information published on the FDA’s website.
The inspection’s concluding report found that Lenox Hill Hospital was not required to address or correct any aspect of the organization’s operational practices.
The FDA regularly inspects sites nationwide to assess whether workplaces and their products follow FDA-regulated standards aimed at protecting public health. The agency publishes these inspection findings as part of its transparency efforts.
The FDA’s website states the agency primarily oversees the safety and quality of human and animal drugs, biological products, medical devices and tobacco products distributed in the United States.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
